{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:27:17Z","timestamp":1787772437562,"version":"build-2784847793"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Mucormycosis is an invasive fungal infection that has been increasing in incidence over the years. Increase in the number of diabetics, malignancy patients, and use of immunosuppressants has mainly led to this gradual upward surge. Mucormycosis has various clinical forms, including rhino-orbito-cerebral, pulmonary, gastrointestinal, and cutaneous. Fungi belonging to Mucorales are thermotolerant and ubiquitous, found growing on organic substrates such as bread, decaying fruits and vegetables, crop debris in soil, compost, and animal excreta. During this second wave of the COVID-19 pandemic, the number of cases of mucormycosis has increased manifold in a short span of time. Associated comorbidity of diabetes mellitus, increased use of higher doses and prolonged duration of systemic corticosteroids, the glucogenic and prothrombotic propensity of the virus, hypoxic environment, COVID pneumonia, increased hospitalization, ICU admissions, and mechanical ventilation have all contributed toward this high rise in numbers. The rhin-orbito-cerebral form is the commonest manifestation of mucormycosis in COVID.\n                      <jats:italic toggle=\"yes\">Rhizopus oryzae<\/jats:italic>\n                      , the main species causing mucormycosis, is identified by hyaline, sparsely-septate, broad, ribbon-like hyphae with irregular right-angle branching ribbon-like hyphae with rhizoids. For the early diagnosis of this infection, 10% KOH mount is very important. These fungi are very rapidly growing and thus can be differentiated from their main ally, Aspergillus. Treatment is mainly in the form of extensive surgical debridement along with liposomal amphotericin B. Posaconazole and isavuconazole are second-line agents, which can also be used for maintenance. Control of diabetes and COVID-19, along with judicious use of antibiotics and systemic corticosteroids, are equally important as management strategies in these pandemic times.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijd.ijd_477_21","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T12:21:06Z","timestamp":1716985266000},"page":"393-400","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Mucormycosis"],"prefix":"10.4103","volume":"66","author":[{"given":"Biju","family":"Vasudevan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandita","family":"Hazra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KP","family":"Shijith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shekhar","family":"Neema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senkadhir","family":"Vendhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20240829","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/s-0039-3401992","article-title":"Mucormycosis","volume":"41","author":"Reid","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"key":"R2-11-20240829","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1177\/1060028016655425","article-title":"Breaking the mold: A review of mucormycosis and current pharmacological treatment options","volume":"50","author":"Riley","year":"2016","journal-title":"Ann Pharmacother"},{"key":"R3-11-20240829","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1093\/cid\/cir865","article-title":"Pathogenesis of mucormycosis","volume":"54(Suppl 1)","author":"Ibrahim","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R5-11-20240829","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/jof6040265","article-title":"Epidemiology and diagnosis of mucormycosis: An update","volume":"6","author":"Skiada","year":"2020","journal-title":"J Fungi (Basel"},{"key":"R6-11-20240829","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/myc.12392","article-title":"Estimated burden of fungal infections in Germany","volume":"58","author":"Ruhnke","year":"2015","journal-title":"Mycoses"},{"key":"R7-11-20240829","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/mmy\/myy060","article-title":"A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment","volume":"57","author":"Prakash","year":"2019","journal-title":"Med Mycol"},{"key":"R8-11-20240829","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12281-013-0152-z","article-title":"Epidemiology of mucormycosis in India","volume":"7","author":"Chakrabarti","year":"2013","journal-title":"Curr Fungal Infect Rep"},{"key":"R9-11-20240829","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: A review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R10-11-20240829","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/13693780903059477","article-title":"Epidemiology of mucormycosis: Review of 18 cases in a tertiary care hospital","volume":"48","author":"Saegeman","year":"2010","journal-title":"Med Mycol"},{"key":"R11-11-20240829","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1017\/S0022215121000992","article-title":"Post coronavirus disease mucormycosis: A deadly addition to the pandemic spectrum","volume":"135","author":"Sharma","year":"2021","journal-title":"J Laryngol Otol"},{"key":"R12-11-20240829","first-page":"e10726","article-title":"Rhino-orbital mucormycosis associated with COVID-19","volume":"12","author":"Mehta","year":"2020","journal-title":"Cureus"},{"key":"R13-11-20240829","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0030-6665(00)80008-0","article-title":"An algorithmic approach to the diagnosis and management of invasive fungal rhinosinusitis in the immunocompromised patient","volume":"33","author":"Gillespie","year":"2000","journal-title":"Otolaryngol Clin North Am"},{"key":"R14-11-20240829","doi-asserted-by":"crossref","first-page":"e1006408","DOI":"10.1371\/journal.ppat.1006408","article-title":"Molecular mechanisms of mucormycosis-The bitter and the sweet","volume":"13","author":"Baldin","year":"2017","journal-title":"PLoS Pathog"},{"key":"R15-11-20240829","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/jof5010026","article-title":"Global epidemiology of mucormycosis","volume":"5","author":"Prakash","year":"2019","journal-title":"J Fungi (Basel"},{"key":"R16-11-20240829","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1439-0507.2007.01364.x","article-title":"Rhinocerebral mucormycosis: The disease spectrum in 27 patients","volume":"50","author":"Mohindra","year":"2007","journal-title":"Mycoses"},{"key":"R17-11-20240829","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jaad.2004.07.027","article-title":"Bull's - eye cutaneous infarcts of zygomycosis: A bed side diagnosis confirmed by touch preparation","volume":"51","author":"Rubin","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"R18-11-20240829","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archotol.1958.00730020739010","article-title":"Cerebral mucor-mycosis: A report of 3 cases","volume":"68","author":"Smith","year":"1950","journal-title":"Arch Otolaryng (Chicago"},{"key":"R19-11-20240829","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.anl.2008.07.003","article-title":"Rhinocerebral mucormycosis: Consideration of prognostic factors and treatment modality","volume":"36","author":"Jung","year":"2009","journal-title":"Auris Nasus Larynx"},{"key":"R20-11-20240829","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/28.suppl_A.13","article-title":"The clinical presentation and diagnosis of invasive fungal infections","volume":"28","author":"Maartens","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"R21-11-20240829","first-page":"12","article-title":"Clinical analysis of 146 patients with critical severe acute respiratory syndrome in Beijing areas","volume":"1","author":"Yin","year":"2004","journal-title":"Clin J Emerg Med"},{"key":"R22-11-20240829","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11046-020-00462-9","article-title":"Fungal co-infections associated with global COVID-19 PANDEMIC: A clinical and diagnostic perspective from China","volume":"185","author":"Song","year":"2020","journal-title":"Mycopathologia"},{"key":"R23-11-20240829","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJM199707243370407","article-title":"Fungal sinusitis","volume":"337","author":"DeShazo","year":"1997","journal-title":"N Engl J Med"},{"key":"R24-11-20240829","doi-asserted-by":"crossref","first-page":"810.e1","DOI":"10.1016\/j.cmi.2015.12.006","article-title":"Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: Retrospective analysis of 44 cases collected through the French surveillance network of invasive fungal infections (RESSIF)","volume":"22","author":"Millon","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"R25-11-20240829","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s00330-017-5007-5","article-title":"Pulmonary mucormycosis: Serial morphologic changes on computed tomography correlate with clinical and pathologic findings","volume":"28","author":"Nam","year":"2018","journal-title":"Eur Radiol"},{"key":"R27-11-20240829","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11046-021-00528-2","article-title":"Coronavirus disease (Covid-19) associated mucormycosis (CAM): Case report and systematic review of literature","volume":"186","author":"Garg","year":"2021","journal-title":"Mycopathologia"},{"key":"R28-11-20240829","doi-asserted-by":"crossref","first-page":"e0248029","DOI":"10.1371\/journal.pone.0248029","article-title":"First and second waves of coronavirus disease-19: A comparative study in hospitalized patients in Reus, Spain","volume":"16","author":"Iftimie","year":"2021","journal-title":"PLoS One"},{"key":"R29-11-20240829","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2217\/fmb.13.78","article-title":"Epidemiology and treatment of mucormycosis","volume":"8","author":"Lewis","year":"2013","journal-title":"Future Microbiol"},{"key":"R30-11-20240829","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1093\/clinids\/14.Supplement_1.S126","article-title":"Mucormycosis","volume":"14","author":"Sugar","year":"1992","journal-title":"Clin Infect Dis"},{"key":"R31-11-20240829","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1590\/abd1806-4841.20176614","article-title":"Cutaneous mucormycosis","volume":"92","author":"Castrej\u00f3n-P\u00e9rez","year":"2017","journal-title":"An Bras Dermatol"},{"key":"R32-11-20240829","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.1016\/j.bjps.2008.04.040","article-title":"Cutaneous mucormycosis: Report of five cases and review of the literature","volume":"62","author":"Arn\u00e1iz-Garc\u00eda","year":"2009","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R33-11-20240829","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/jof4020046","article-title":"Mucormycosis: Battle with the deadly enemy over a five-year period in India","volume":"4","author":"Chander","year":"2018","journal-title":"J Fungi (Basel"},{"key":"R34-11-20240829","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11908-010-0129-9","article-title":"Recent advances in the treatment of mucormycosis","volume":"12","author":"Spellberg","year":"2010","journal-title":"Curr Infect Dis Rep"},{"key":"R35-11-20240829","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/QCO.0000000000000008","article-title":"Update on mucormycosis pathogenesis","volume":"26","author":"Ibrahim","year":"2013","journal-title":"Curr Opin Infect Dis"},{"key":"R36-11-20240829","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/QCO.0b013e3283165fd1","article-title":"Iron acquisition: A novel perspective on mucormycosis pathogenesis and treatment","volume":"21","author":"Ibrahim","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"R37-11-20240829","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archopht.1997.01100160089018","article-title":"Iron overload is a risk factor for zygomycosis","volume":"115","author":"McNab","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"R38-11-20240829","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/CMR.00053-10","article-title":"Histopathologic diagnosis of fungal infections in the 21st century","volume":"24","author":"Guarner","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"R39-11-20240829","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2217\/fmb.14.23","article-title":"Laboratory diagnosis of mucormycosis: Current status and future perspectives","volume":"9","author":"Lackner","year":"2014","journal-title":"Future Microbiol"},{"key":"R40-11-20240829","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica"},{"key":"R41-11-20240829","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/428780","article-title":"Zygomycosis in a tertiary-care cancer center in the era of Aspergillus- active antifungal therapy: A case-control observational study of 27 recent cases","volume":"191","author":"Kontoyiannis","year":"2005","journal-title":"J Infect Dis"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_477_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:46:29Z","timestamp":1787769989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_477_21"}},"subtitle":["The Scathing Invader"],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_477_21","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}